Local inflammation is associated with aortic thrombus formation in abdominal aortic aneurysms

Summary

Intraluminal thrombus formation in aortic abdominal aneurysms (AAA) is associated with adverse clinical prognosis. Interplay between coagulation and inflammation, characterised by leukocyte infiltration and cytokine production, has been implicated in AAA thrombus formation. We studied leukocyte (CD45+) content by flow cytometry in AAA thrombi from 27 patients undergoing surgical repair. Luminal parts of thrombi were leukocyte-rich, while abluminal segments showed low leukocyte content. CD66b+ granulocytes were the most prevalent, but their content was similar to blood. Monocytes (CD14+) and T cells (CD3+) were also abundant, while content of B lymphocytes (CD19+) and NK cells (CD56+CD16+) were low. Thrombi showed comparable content of CD14highCD16− monocytes and lower CD14highCD16+ and CD14dimCD16+, than blood. Monocytes were activated with high CD11b, CD11c and HLA-DR expression. Total T cell content was decreased in AAA thrombus compared to peripheral blood but CD8 and CD3+CD4-CD8− (double negative T cell) contents were increased in thrombi. CD4+ cells were lower but highly activated (high CD69, CD25 and HLA-DR). No differences in T regulatory (CD4+CD25+FoxP3+) cell or pro-atherogenic CD4+CD28null lymphocyte content were observed between thrombi and blood. Thrombus T cells expressed high levels of CCR5 receptor for chemokine RANTES, commonly released from activated platelets. Leukocyte or T cell content in thrombi was not correlated with aneurysm size. However, CD3+ content was significantly associated with smoking in multivariate analysis taking into account major risk factors for atherosclerosis. In conclusion, intraluminal AAA thrombi are highly inflamed, predominantly with granulocytes, CD14highCD16− monocytes and activated T lymphocytes. Smoking is associated with T cell infiltration in AAA intraluminal thrombi.

Keywords

Thrombus - aortic abdominal aneurysm - inflammation - monocyte - T cell

• References

• 1 Weintraub NL. Understanding abdominal aortic aneurysm. N Engl J Med 2009; 361: 1114-1116.
• 2 Satta J, Laara E, Juvonen T. Intraluminal thrombus predicts rupture of an abdominal aortic aneurysm. J Vasc Surg 1996; 23: 737-739.
• 3 Parr A, McCann M, Bradshaw B. et al. Thrombus volume is associated with cardiovascular events and aneurysm growth in patients who have abdominal aortic aneurysms. J Vasc Surg 2011; 53: 28-35.
• 4 Speelman L, Schurink GW, Bosboom EM. et al. The mechanical role of thrombus on the growth rate of an abdominal aortic aneurysm. J Vasc Surg 2010; 51: 19-26.
• 5 Ashton JH, Vande Geest JP, Simon BR. et al. Compressive mechanical properties of the intraluminal thrombus in abdominal aortic aneurysms and fibrin-based thrombus mimics. J Biomech 2009; 42: 197-201.
• 6 Matusik P, Mazur P, Stepien E. et al. Architecture of intraluminal thrombus removed from abdominal aortic aneurysm. J Thromb Thrombolysis 2010; 30: 7-9.
• 7 Silvain J, Collet JP, Nagaswami C. et al. Composition of coronary thrombus in acute myocardial infarction. J Am Coll Cardiol 2011; 57: 1359-1367.
• 8 Adolph R, Vorp DA, Steed DL. et al. Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm. J Vasc Surg 1997; 25: 916-926.
• 9 Fontaine V, Jacob MP, Houard X. et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 2002; 161: 1701-1710.
• 10 Fontaine V, Touat Z, Mtairag el M. et al. Role of leukocyte elastase in preventing cellular re-colonization of the mural thrombus. Am J Pathol 2004; 164: 2077-2087.
• 11 Kato K, Matsubara T, Iida K. et al. Elevated levels of pro-inflammatory cytokines in coronary artery thrombi. Int J Cardiol 1999; 70: 267-273.
• 12 Aho PS, Niemi T, Piilonen A. et al. Interplay between coagulation and inflammation in open and endovascular abdominal aortic aneurysm repair--impact of intra-aneurysmal thrombus. Scand J Surg 2007; 96: 229-235.
• 13 Wyss CA, Neidhart M, Altwegg L. et al. Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. Eur Heart J 2010; 31: 1457-1469.
• 14 Davies RS, Abdelhamid M, Vohra RK. et al The relationship between aortic aneurysm sac thrombus volume on coagulation, fibrinolysis and platelet activity. Thromb Res 2012; 130: 463-466.
• 15 Ramos-Mozo P, Madrigal-Matute J, Martinez-Pinna R. et al. Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a novel biomarker of abdominal aortic aneurysm: potential implication of oxidative stress in abdominal aortic aneurysm progression. Arterioscler Thromb Vasc Biol 2011; 31: 3011-3019.
• 16 Houard X, Ollivier V, Louedec L. et al. Differential inflammatory activity across human abdominal aortic aneurysms reveals neutrophil-derived leukotriene B4 as a major chemotactic factor released from the intraluminal thrombus. FASEB J 2009; 23: 1376-1383.
• 17 Tanaseanu C, Neagu M, Popescu M. et al. Peripheral leukocytes activation in aortic aneurysmal disease. Rom J Intern Med 1998; 36: 167-174.
• 18 Davies MJ. Reactive oxygen species, metalloproteinases, and plaque stability. Circulation 1998; 97: 2382-2383.
• 19 Rajagopalan S, Meng XP, Ramasamy S. et al. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996; 98: 2572-2579.
• 20 Ulrich C, Heine GH, Gerhart MK. et al. Proinflammatory CD14+CD16+ monocytes are associated with subclinical atherosclerosis in renal transplant patients. Am J Transplant 2008; 8: 103-110.
• 21 Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007; 81: 584-592.
• 22 Schlitt A, Heine GH, Blankenberg S. et al. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels. Thromb Haemost 2004; 92: 419-424.
• 23 von Bubnoff D, Scheler M, Hinz T. et al. Comparative immunophenotyping of monocytes from symptomatic and asymptomatic atopic individuals. Allergy 2004; 59: 933-939.
• 24 Berg KE, Ljungcrantz I, Andersson L. et al. Elevated CD14++CD16- monocytes predict cardiovascular events. Circ Cardiovasc Genet 2012; 5: 122-131.
• 25 Harrison DG, Guzik TJ, Lob HE. et al. Inflammation, immunity, and hypertension. Hypertension 2011; 57: 132-140.
• 26 Anand A, Dean GS, Quereshi K. et al. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers. Lupus 2002; 11: 493-500.
• 27 Ascon DB, Ascon M, Satpute S. et al. Normal mouse kidneys contain activated and CD3+CD4- CD8- double-negative T lymphocytes with a distinct TCR repertoire. J Leukoc Biol 2008; 84: 1400-1409.
• 28 D'Acquisto F, Crompton T. CD3+CD4-CD8− (double negative) T cells: saviours or villains of the immune response?. Biochem Pharmacol 2011; 82: 333-340.
• 29 Papiernik M, Pontoux C. In vivo and in vitro repertoire of CD3+CD4-CD8− thymocytes. Int Immunol 1990; 2: 407-412.
• 30 Gollob KJ, Antonelli LR, Faria DR. et al. Immunoregulatory mechanisms and CD4-CD8- (double negative) T cell subpopulations in human cutaneous leishmaniasis: a balancing act between protection and pathology. Int Immunopharmacol 2008; 8: 1338-1343.
• 31 Guzik TJ, Hoch NE, Brown KA. et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007; 204: 2449-2460.
• 32 Yin M, Zhang J, Wang Y. et al. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2010; 30: 1825-1831.
• 33 Liuzzo G, Biasucci LM, Trotta G. et al. Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol 2007; 50: 1450-1458.
• 34 Mause SF, von Hundelshausen P, Zernecke A. et al. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005; 25: 1512-1518.
• 35 Badimon L, Storey RF, Vilahur G. Update on lipids, inflammation and atherothrombosis. Thromb Haemost 2011; 105 (Suppl. 01) S34-S42.
• 36 Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med 2010; 38: S26-S34.
• 37 Weber C. Chemokines in atherosclerosis, thrombosis, and vascular biology. Arterioscler Thromb Vasc Biol 2008; 28: 1896.
• 38 Cerletti C, Tamburrelli C, Izzi B. et al. Platelet-leukocyte interactions in thrombosis. Thromb Res 2012; 129: 263-266.
• 39 Seizer P, Gawaz M, May AE. Platelet-monocyte interactions--a dangerous liaison linking thrombosis, inflammation and atherosclerosis. Curr Med Chem 2008; 15: 1976-1980.
• 40 Hirahashi J, Hishikawa K, Kaname S. et al. Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury. Circulation 2009; 120: 1255-1265.
• 41 Shebuski RJ, Kilgore KS. Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther 2002; 300: 729-735.
• 42 Marvar PJ, Thabet SR, Guzik TJ. et al. Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 2010; 107: 263-270.
• 43 Urbonavicius S, Urbonaviciene G, Honore B. et al. Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture--a systematic review. Eur J Vasc Endovasc Surg 2008; 36: 273-282.
• 44 Duftner C, Seiler R, Klein-Weigel P. et al. High prevalence of circulating CD4+CD28- T-cells in patients with small abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2005; 25: 1347-1352.
• 45 Matusik P, Guzik B, Weber C. et al. Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice?. Thromb Haemost 2012; 108: 443-456.